What is Amarin's earnings per share (EPS)?

Amarin (AMRN) reported diluted earnings per share of $-0.09 for fiscal year 2025. This represents a 55.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Amarin Financials

AMRN

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Amarin (AMRN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 36/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Amarin has an operating margin of -23.5%, meaning the company retains $-23 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -40.2% the prior year.

Growth

Amarin's revenue declined 6.5% year-over-year, from $228.6M to $213.6M. This contraction results in a growth score of 22/100.

Leverage

Amarin carries a low D/E ratio of 0.46, meaning only $0.46 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 93/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

With a current ratio of 3.34, Amarin holds $3.34 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 65/100.

Returns

Amarin generates a -8.5% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is up from -16.9% the prior year.

Piotroski F-Score Neutral

5/9

Amarin passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

-0.17x

For every $1 of reported earnings, Amarin generates $-0.17 in operating cash flow ($6.7M OCF vs -$38.8M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

-7167.1x

Amarin earns $-7167.1 in operating income for every $1 of interest expense (-$50.2M vs $7K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$213.6M

YoY-6.5%

5Y CAGR-19.0%

10Y CAGR+10.1%

Amarin generated $213.6M in revenue in fiscal year 2025. This represents a decrease of 6.5% from the prior year.

EBITDA

N/A

Net Income

-$38.8M

YoY+52.8%

Amarin reported -$38.8M in net income in fiscal year 2025. This represents an increase of 52.8% from the prior year.

EPS (Diluted)

$-0.09

YoY+55.0%

Amarin earned $-0.09 per diluted share (EPS) in fiscal year 2025. This represents an increase of 55.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$134.7M

YoY+11.3%

5Y CAGR-6.4%

10Y CAGR+2.3%

Amarin held $134.7M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

416M

YoY+1.1%

5Y CAGR+1.2%

10Y CAGR+8.5%

Amarin had 416M shares outstanding in fiscal year 2025. This represents an increase of 1.1% from the prior year.

Margins & Returns

Gross Margin

56.6%

YoY+21.0pp

5Y CAGR-22.0pp

10Y CAGR-9.3pp

Amarin's gross margin was 56.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 21.0 percentage points from the prior year.

Operating Margin

-23.5%

YoY+16.7pp

5Y CAGR-20.3pp

10Y CAGR+96.7pp

Amarin's operating margin was -23.5% in fiscal year 2025, reflecting core business profitability. This is up 16.7 percentage points from the prior year.

Net Margin

-18.2%

YoY+17.8pp

5Y CAGR-15.2pp

10Y CAGR+122.8pp

Amarin's net profit margin was -18.2% in fiscal year 2025, showing the share of revenue converted to profit. This is up 17.8 percentage points from the prior year.

Return on Equity

-8.5%

YoY+8.5pp

5Y CAGR-5.6pp

Amarin's ROE was -8.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 8.5 percentage points from the prior year.

Capital Allocation

R&D Spending

$19.8M

YoY-5.1%

5Y CAGR-12.7%

10Y CAGR-9.0%

Amarin invested $19.8M in research and development in fiscal year 2025. This represents a decrease of 5.1% from the prior year.

Share Buybacks

N/A

Capital Expenditures

N/A

AMRN Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$213.6M-6.5%	$228.6M-25.5%	$306.9M-16.9%	$369.2M-36.7%	$583.2M-5.0%	$614.1M
Cost of Revenue	N/A	N/A	N/A	N/A	$121.3M-7.7%	$131.4M
Gross Profit	$120.9M+48.5%	$81.4M-50.8%	$165.5M-31.7%	$242.5M-47.5%	$461.9M-4.3%	$482.6M
R&D Expenses	$19.8M-5.1%	$20.9M-6.1%	$22.2M-26.9%	$30.4M+3.8%	$29.3M-24.8%	$39.0M
SG&A Expenses	$115.0M-24.5%	$152.3M-23.8%	$199.9M-34.3%	$304.4M-25.4%	$408.3M-11.9%	$463.3M
Operating Income	-$50.2M+45.3%	-$91.8M-35.8%	-$67.6M+36.2%	-$105.9M-1108.1%	$10.5M+153.4%	-$19.7M
Interest Expense	$7K0.0%	$7K-12.5%	$8K-46.7%	$15K-88.4%	$129K-95.0%	$2.6M
Income Tax	$2.8M-44.8%	$5.0M-8.4%	$5.4M+172.4%	$2.0M-43.9%	$3.6M+378.1%	$745K
Net Income	-$38.8M+52.8%	-$82.2M-39.0%	-$59.1M+44.1%	-$105.8M-1468.9%	$7.7M+142.9%	-$18.0M
EPS (Diluted)	$-0.09+55.0%	$-0.20-33.3%	$-0.15+42.3%	$-0.26-1400.0%	$0.02+140.0%	$-0.05

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$49.2M-0.9%	$49.7M-31.7%	$72.7M+73.1%	$42.0M-32.6%	$62.3M+47.3%	$42.3M-37.3%	$67.5M+19.4%	$56.5M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	$23.2M+4.3%	$22.2M-55.9%	$50.4M+100.4%	$25.1M+362.7%	-$9.6M-158.8%	$16.3M-61.9%	$42.8M+34.1%	$31.9M
R&D Expenses	$5.4M+27.6%	$4.2M-14.4%	$4.9M-7.5%	$5.3M-11.2%	$6.0M+31.8%	$4.5M-4.3%	$4.7M-15.2%	$5.6M
SG&A Expenses	$20.1M+1.8%	$19.7M-49.1%	$38.7M+5.7%	$36.6M-1.1%	$37.0M+0.2%	$36.9M-4.3%	$38.5M-3.4%	$39.9M
Operating Income	-$6.3M+43.0%	-$11.1M+30.5%	-$16.0M+4.6%	-$16.8M+68.1%	-$52.5M-108.7%	-$25.2M-4703.1%	-$524K+96.1%	-$13.6M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$371K+198.4%	-$377K-154.7%	$689K-66.7%	$2.1M+260.2%	-$1.3M-135.8%	$3.6M+163.1%	$1.4M+5.5%	$1.3M
Net Income	-$1.2M+84.2%	-$7.7M+45.3%	-$14.1M+9.9%	-$15.7M+67.7%	-$48.6M-93.4%	-$25.1M-1751.4%	$1.5M+115.3%	-$10.0M
EPS (Diluted)	N/A	$-0.02+33.3%	$-0.03+25.0%	$-0.04	N/A	$-0.06	$0.00+100.0%	$-0.02

AMRN Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$670.8M-2.1%	$685.3M-17.6%	$831.7M-6.1%	$886.2M-17.0%	$1.1B+10.6%	$966.0M
Current Assets	$649.9M+9.2%	$595.4M-17.9%	$725.0M+5.2%	$689.1M-21.6%	$878.7M-0.1%	$879.2M
Cash & Equivalents	$134.7M+11.3%	$121.0M-39.3%	$199.3M-8.5%	$217.7M-0.8%	$219.5M+17.4%	$187.0M
Inventory	$195.9M+18.0%	$166.0M-35.8%	$258.6M+13.1%	$228.7M-2.5%	$234.7M+24.3%	$188.9M
Accounts Receivable	$126.8M+3.7%	$122.3M-8.4%	$133.6M+2.0%	$131.0M-20.0%	$163.7M+5.9%	$154.6M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$211.5M+6.2%	$199.2M-28.8%	$279.6M-3.9%	$290.8M-27.5%	$401.0M+18.4%	$338.5M
Current Liabilities	$194.5M+8.1%	$179.9M-30.6%	$259.3M-0.1%	$259.5M-30.0%	$370.7M+20.6%	$307.4M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$459.3M-5.5%	$486.2M-11.9%	$552.1M-7.3%	$595.3M-10.8%	$667.1M+6.3%	$627.5M
Retained Earnings	-$1.7B-2.3%	-$1.7B-5.2%	-$1.6B-3.9%	-$1.5B-7.4%	-$1.4B+0.5%	-$1.4B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$670.8M+1.7%	$659.8M-1.5%	$670.1M+2.2%	$655.7M-4.3%	$685.3M-8.7%	$750.6M-6.2%	$799.9M+1.2%	$790.0M
Current Assets	$649.9M+3.4%	$628.3M+3.5%	$606.8M+5.9%	$573.1M-3.8%	$595.4M-8.4%	$650.2M-7.4%	$701.8M+2.0%	$687.9M
Cash & Equivalents	$134.7M+9.7%	$122.8M-17.0%	$147.9M+23.7%	$119.5M-1.3%	$121.0M-22.9%	$156.9M-27.3%	$215.9M+0.9%	$213.9M
Inventory	$195.9M+6.1%	$184.7M+7.9%	$171.2M+7.4%	$159.5M-3.9%	$166.0M-25.9%	$224.0M-6.4%	$239.4M-6.2%	$255.3M
Accounts Receivable	$126.8M-0.4%	$127.3M+6.9%	$119.1M+11.6%	$106.7M-12.7%	$122.3M+8.6%	$112.6M-8.9%	$123.7M+6.8%	$115.8M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$211.5M+5.3%	$200.9M-2.1%	$205.2M+12.8%	$182.0M-8.6%	$199.2M-9.2%	$219.2M-11.6%	$248.0M+1.6%	$244.1M
Current Liabilities	$194.5M+6.7%	$182.2M-2.0%	$185.9M+14.5%	$162.4M-9.7%	$179.9M-10.7%	$201.6M-12.6%	$230.5M+2.7%	$224.4M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$459.3M+0.1%	$458.9M-1.3%	$464.9M-1.8%	$473.7M-2.6%	$486.2M-8.5%	$531.4M-3.7%	$551.9M+1.1%	$545.9M
Retained Earnings	-$1.7B-0.1%	-$1.7B-0.5%	-$1.7B-0.8%	-$1.7B-0.9%	-$1.7B-3.0%	-$1.6B-1.6%	-$1.6B+0.1%	-$1.6B

AMRN Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$6.7M+121.7%	-$31.0M-550.9%	$6.9M+103.8%	-$180.1M-170.7%	-$66.5M-206.0%	-$21.7M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	$252K
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	-$22.0M
Investing Cash Flow	$8.8M+119.2%	-$46.0M-80.1%	-$25.5M-114.6%	$175.3M+68.4%	$104.1M+127.6%	-$377.0M
Financing Cash Flow	-$2.0M-41.0%	-$1.4M-727.4%	$230K+160.7%	-$379K+92.5%	-$5.1M+91.4%	-$58.9M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$15.3M+220.3%	-$12.7M-176.5%	$16.6M+233.3%	-$12.5M+6.4%	-$13.3M-464.0%	-$2.4M+14.2%	-$2.7M+78.2%	-$12.6M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$3.5M+71.0%	-$12.1M-197.7%	$12.4M+2.9%	$12.1M+152.8%	-$22.8M+59.6%	-$56.6M-1304.5%	$4.7M-83.7%	$28.7M
Financing Cash Flow	-$4K+98.4%	-$248K+62.6%	-$663K+40.8%	-$1.1M-6682.4%	$17K+125.0%	-$68K-300.0%	$34K+102.4%	-$1.4M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

AMRN Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	56.6%+21.0pp	35.6%-18.3pp	53.9%-11.7pp	65.7%-13.5pp	79.2%+0.6pp	78.6%
Operating Margin	-23.5%+16.7pp	-40.2%-18.1pp	-22.0%+6.7pp	-28.7%-30.5pp	1.8%+5.0pp	-3.2%
Net Margin	-18.2%+17.8pp	-35.9%-16.7pp	-19.3%+9.4pp	-28.7%-30.0pp	1.3%+4.3pp	-2.9%
Return on Equity	-8.5%+8.5pp	-16.9%-6.2pp	-10.7%+7.1pp	-17.8%-18.9pp	1.2%+4.0pp	-2.9%
Return on Assets	-5.8%+6.2pp	-12.0%-4.9pp	-7.1%+4.8pp	-11.9%-12.7pp	0.7%+2.6pp	-1.9%
Current Ratio	3.34+0.0	3.31+0.5	2.80+0.1	2.66+0.3	2.37-0.5	2.86
Debt-to-Equity	0.46+0.1	0.41-0.1	0.51+0.0	0.49-0.1	0.60+0.1	0.54
FCF Margin	N/A	N/A	N/A	N/A	N/A	-3.6%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	47.1%+2.4pp	44.7%-24.5pp	69.2%+9.4pp	59.8%+75.2pp	-15.3%-53.8pp	38.5%-24.9pp	63.4%+6.9pp	56.5%
Operating Margin	-12.9%+9.5pp	-22.4%-0.4pp	-22.0%+17.9pp	-39.9%+44.4pp	-84.3%-24.8pp	-59.5%-58.7pp	-0.8%+23.3pp	-24.0%
Net Margin	-2.5%+13.1pp	-15.6%+3.9pp	-19.4%+17.9pp	-37.4%+40.7pp	-78.0%-18.6pp	-59.4%-61.7pp	2.3%+19.9pp	-17.6%
Return on Equity	-0.3%+1.4pp	-1.7%+1.4pp	-3.0%+0.3pp	-3.3%+6.7pp	-10.0%-5.3pp	-4.7%-5.0pp	0.3%+2.1pp	-1.8%
Return on Assets	-0.2%+1.0pp	-1.2%+0.9pp	-2.1%+0.3pp	-2.4%+4.7pp	-7.1%-3.7pp	-3.4%-3.5pp	0.2%+1.5pp	-1.3%
Current Ratio	3.34-0.1	3.45+0.2	3.26-0.3	3.53+0.2	3.31+0.1	3.23+0.2	3.04-0.0	3.07
Debt-to-Equity	0.46+0.0	0.440.0	0.44+0.1	0.38-0.0	0.410.0	0.41-0.0	0.450.0	0.45
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Scilex Holding Co SCLX

$52.3M

Kamada Ltd KMDA

$488.6M

Esperion Therape ESPR

$670.3M

Emergent Biosolutions Inc EBS

$425.0M

ORGANON & CO OGN

$1.7B

Frequently Asked Questions

What is Amarin's annual revenue?

Amarin (AMRN) reported $213.6M in total revenue for fiscal year 2025. This represents a -6.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Amarin's revenue growing?

Amarin (AMRN) revenue declined by 6.5% year-over-year, from $228.6M to $213.6M in fiscal year 2025.

Is Amarin profitable?

No, Amarin (AMRN) reported a net income of -$38.8M in fiscal year 2025, with a net profit margin of -18.2%.

What is Amarin's gross margin?

Amarin (AMRN) had a gross margin of 56.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Amarin's operating margin?

Amarin (AMRN) had an operating margin of -23.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Amarin's net profit margin?

Amarin (AMRN) had a net profit margin of -18.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Amarin's return on equity (ROE)?

Amarin (AMRN) has a return on equity of -8.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Amarin's operating cash flow?

Amarin (AMRN) generated $6.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Amarin's total assets?

Amarin (AMRN) had $670.8M in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Amarin spend on research and development?

Amarin (AMRN) invested $19.8M in research and development during fiscal year 2025.

How many shares does Amarin have outstanding?

Amarin (AMRN) had 416M shares outstanding as of fiscal year 2025.

What is Amarin's current ratio?

Amarin (AMRN) had a current ratio of 3.34 as of fiscal year 2025, which is generally considered healthy.

What is Amarin's debt-to-equity ratio?

Amarin (AMRN) had a debt-to-equity ratio of 0.46 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Amarin's return on assets (ROA)?

Amarin (AMRN) had a return on assets of -5.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Amarin's Piotroski F-Score?

Amarin (AMRN) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Amarin's earnings high quality?

Amarin (AMRN) has an earnings quality ratio of -0.17x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Amarin cover its interest payments?

Amarin (AMRN) has an interest coverage ratio of -7167.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Amarin?

Amarin (AMRN) scores 36 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.